Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (55)

2022

  1. Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies

    Journal of Translational Autoimmunity, Vol. 5

  2. Long-term Outcomes and Recovery of Patients who Survived COVID-19: LUNG INJURY COVID-19 Study

    Open Forum Infectious Diseases, Vol. 9, Núm. 4

  3. Testing for Vitamin D in High-Risk COPD in Outpatient Clinics in Spain: A Cross-Sectional Analysis of the VITADEPOC Study

    Journal of Clinical Medicine, Vol. 11, Núm. 5

2021

  1. Accelerated immunosenescence, oxidation and inflammation lead to a higher biological age in COPD patients

    Experimental Gerontology, Vol. 154

  2. Assessing the usefulness of the prevexair smartphone application in the follow-up high-risk patients with COPD

    International Journal of COPD, Vol. 16, pp. 53-65

  3. Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

2020

  1. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: Data from the NEREA Registry: Reply

    Rheumatology (United Kingdom)

  2. Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 3, pp. e15699

  3. Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study

    JMIR mHealth and uHealth, Vol. 8, Núm. 3, pp. e15699

  4. Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: Data from the NEREA Registry

    Rheumatology (United Kingdom), Vol. 59, Núm. 8, pp. 2099-2108

2016

  1. Health literacy and health outcomes in chronic obstructive pulmonary disease

    Respiratory Medicine, Vol. 115, pp. 78-82

2013

  1. Macitentan for the treatment of idiopathic pulmonary fibrosis: The randomised controlled MUSIC trial

    European Respiratory Journal, Vol. 42, Núm. 6, pp. 1622-1632

2011

  1. Neutral sphingomyelinase, NADPH oxidase and reactive oxygen species. Role in acute hypoxic pulmonary vasoconstriction

    Journal of Cellular Physiology, Vol. 226, Núm. 10, pp. 2633-2640

2010

  1. Factors associated with the control of severe asthma

    Journal of Asthma, Vol. 47, Núm. 2, pp. 124-130

2009

  1. Dolor torácico y hemoptisis

    Revista de Patologia Respiratoria, Vol. 12, Núm. SUPPL.1, pp. 83-85

2007

  1. Directrices para el desarrollo y la evaluación de guías terapéuticas: Elementos y recomendaciones para su diseño y elaboración

    Medicina Clinica, Vol. 128, Núm. 3, pp. 100-110

  2. Fenotipos de la enfermedad pulmonar obstructiva crónica

    Medicina Clinica Monografias, Vol. 8, Núm. 7, pp. 17-22

2006

  1. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population

    Respiratory Medicine, Vol. 100, Núm. 11, pp. 1973-1980

  2. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil

    Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 5, pp. 1762-1767

  3. Noninvasive measurement of the maximum relaxation rate of inspiratory muscles in patients with neuromuscular disorders

    Respiration, Vol. 73, Núm. 4, pp. 474-480